Studies of mutated protein in Lou Gehrig’s disease reveal new paths for drug discovery

Several genes have been linked to ALS, with one of the most recent called FUS. Two new studies examined FUS biology in yeast and found that defects in RNA biology may be central to how FUS contributes to ALS, or Lou Gehrig's disease. These findings point to new targets for developing drugs.

Read the whole article on Science Daily

More from Science Daily